MS DA Site - Ponesimod Mechanism of Action in Multiple Sclerosis

^© Janssen Pharmaceutica NV 2022. This site is published by Janssen Pharmaceutica NV which is solely responsible for its content. This site is intended for use by Healthcare Professionals in Europe, Middle East and Africa.

Cookie Settings